O30 Anti-histone and anti-nucleosome rather than anti-dsDNA antibodies associate with IFN-induced biomarkers in Sudanese and Swedish SLE patients

O30 Anti-histone and anti-nucleosome rather than anti-dsDNA antibodies associate with IFN-induced biomarkers in Sudanese and Swedish SLE patients

Bibliographic Details
Main Authors:	Anders Larsson, Elisabet Svenungsson, Iva Gunnarsson, Vilija Oke, Johan Rönnelid, Jan Nilsson, Elnour M Elagib, Amir Elshafie, Musa AM Nur, Sahwa Elbagir, NasrEldeen A Mohammed
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-03-01
Series:	Lupus Science and Medicine

Similar Items

LP-016 Anti-histone and anti-nucleosome antibodies, rather than anti-dsDNA antibodies are associated with interferon-induced biomarkers in Sudanese and Swedish SLE patients
by: Anders Larsson, et al.
Published: (2023-07-01)

O12 Immune complexes containing anti-dsDNA in patients with systemic lupus erythematosus with renal involvement – Association with renal activity and response to treatment
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

S13.2 Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with hHLA-DRB1 *13 and negatively with HLA-DRB1*03 in SLE
by: J Rönnelid, et al.
Published: (2022-10-01)

P10 IL-16 expression in kidney biopsies from patients with SLE- and antiphosholipid syndrome- associated renal thrombotic microangiopathy and renal IgA vasculitis
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus
by: Živković Valentina, et al.
Published: (2014-01-01)

Co-positivity of anti-dsDNA, anti-nucleosome, and anti-smith autoantibodies as serological biomarkers for disease activity in systemic lupus erythematosus
by: Sahar Abdel-Rahman Elsayed, et al.
Published: (2022-02-01)

Significance of co-positivity for anti-dsDNA, -nucleosome, and -histone antibodies in patients with lupus nephritis
by: Sung-Eun Choi, et al.
Published: (2023-12-01)

Anti‐dsDNA, anti‐nucleosome, anti‐C1q, and anti‐histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity
by: Xiaoying Shang, et al.
Published: (2021-06-01)

IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE)
by: Vilija Oke, et al.
Published: (2017-06-01)

Anti-dsDNA B-Cell ELISpot as a Monitoring and Flare Prediction Tool in SLE Patients
by: Albert Pérez-Isidro, et al.
Published: (2023-02-01)

Anticorpos anti-C1q, anticromatina/nucleossomo e anti-dsDNA em pacientes com lúpus eritematoso sistêmico juvenil Anti-C1q, anti-chromatin/nucleosome, and anti-dsDNA antibodies in juvenile systemic lupus erythematosus patients
by: Adriana Almeida de Jesus, et al.
Published: (2012-12-01)

PO.3.73 Soluble CD200 concentration in serum is increased in SLE patients and correlates with anti-dsdna
by: M Limper, et al.
Published: (2022-10-01)

Co-Positivity for Anti-dsDNA, -Nucleosome and -Histone Antibodies in Lupus Nephritis Is Indicative of High Serum Levels and Severe Nephropathy.
by: Jinfeng Yang, et al.
Published: (2015-01-01)

Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus
by: Azita Sohrabian, et al.
Published: (2019-11-01)

Frequencies and results of anti-nuclear, anti-dsDNA and anti-ENA in a tertiary-care hospital in Karachi, Pakistan
by: Fatima Husain Kanani, et al.
Published: (2020-11-01)

P58 Menopausal age and the effect of menopause on disease activity in SLE
by: Aleksandra Antovic, et al.
Published: (2024-03-01)

Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease.
by: Danilo Villalta, et al.
Published: (2013-01-01)

Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus
by: Maria Infantino, et al.
Published: (2022-01-01)

Anticorpos anti-C1q, anticromatina/nucleossomo e anti-dsDNA em pacientes com lúpus eritematoso sistêmico juvenil [Rev Bras Reumatol 2012; 52(6):971-81] Anti-C1q, anti-chromatin/nucleosome, and anti-dsDNA antibodies in juvenile systemic lupus erythematosus patients [Rev Bras Reumatol 2012; 52(6):971-81]
by: AA Jesus, et al.
Published: (2013-02-01)

Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and Crithidia luciliae assay in a multiethnic racial cohort of patients with SLE
by: Amit Saxena, et al.
Published: (2023-08-01)

Duplex Vertical-Flow Rapid Tests for Point-of-Care Detection of Anti-dsDNA and Anti-Nuclear Autoantibodies
by: Rongwei Lei, et al.
Published: (2024-02-01)

Evaluation of Anti-Nuclear Antibodies and Anti-dsDNA Serum Levels in Patients with Suspected Systemic Lupus Erythematosus
by: Mana Zakeri, et al.
Published: (2023-03-01)

Anti-dsDNA negative and anti-Ro positive lupus nephritis: a report of a rare case
by: D. Jain, et al.
Published: (2014-03-01)

Mechanisms of kidney injury in lupus nephritis - the role of anti-dsDNA antibodies
by: Tak Mao eChan, et al.
Published: (2015-09-01)

Anti-Ribosomal-P Antibody Association with Neuropsychiatric Lupus in Sudanese Patients Attending Rheumatology Clinic in Omdurman Military Hospital
by: Taha ZI, et al.
Published: (2022-11-01)

IS THERE A PLACE FOR ANTI-NUCLEOSOME ANTIBODY ASSESSMENT IN SCLERODERMA?
by: Alexandra Burlui, et al.
Published: (2018-12-01)

Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab
by: L. Punzi, et al.
Published: (2011-09-01)

The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be
by: Ole Petter Rekvig
Published: (2019-05-01)

Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis
by: Anders Larsson, et al.
Published: (2022-07-01)

High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus
by: Vilija Oke, et al.
Published: (2019-04-01)

Electrochemical, spectroscopic, and molecular docking studies of the interaction between the anti-retroviral drug indinavir and dsDNA
by: Fariba Mollarasouli, et al.
Published: (2020-10-01)

Anti- nucleosome antibodies- a valuable test in systemic iupus erythematosus
by: Ahmed A. Abid, et al.
Published: (2011-04-01)

Distribution of anti-nuclear antibodies (ANA), anti-dsdna and extractable nuclear antigens (ENA) antibodies among apparently healthy malay women and determination of ana cutofftitre
by: Che Maraina, Che Hussin
Published: (2013)

Serum IgE anti-dsDNA autoantibodies in patients with proliferative lupus nephritis are associated with tubulointerstitial inflammation
by: Leran Chen, et al.
Published: (2023-12-01)

B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosus
by: Andreas Jönsen, et al.
Published: (2023-10-01)

Study on the value of ANA, ANCA, HLA-B27 and anti-dsDNA in the diagnosis of immune-related uveitis
by: Bing Wang, et al.
Published: (2018-01-01)

Anti-Tumor Studies Of A Selection Of Sudanese Indigenous Herbs Via The Angiogenesis Pathway
by: Hassan, Loiy Elsir Ahmed
Published: (2015)

The Effects of Flexibility on dsDNA–dsDNA Interactions
by: Chuanying Chen, et al.
Published: (2022-05-01)

P12 Sensitivity differences in ELISA versus EliA for detecting anti-dsDNA antibodies: awareness for the clinician
by: Anna Kohn, et al.
Published: (2024-03-01)

1002 Bacterial amyloid curli/eDNA complexes induce NETosis in lupus patients positive for anti-dsDNA
by: Roberto Caricchio, et al.
Published: (2022-12-01)